Skip to main content
. 2022 Mar 11;14:683689. doi: 10.3389/fnagi.2022.683689

TABLE 2.

Number of AD biomarkers and studies for different blood components.

Blood component Number of biomarkers Number of studies Tested parameters and number of studies
Plasma 86 48 Aβ pathology (26), neuroinflammation (8), tau pathology (5), neurodegeneration (3), cholinergic dysfunction (1), oxidative stress (1), energy metabolic dysfunction (1), AD (3)
Serum 41 15 Aβ pathology (6), neuroinflammation (5), tau pathology (1), vascular dysregulation (1), neurodegeneration (1), AD (1)
Exosomes 12 4 Neurodegeneration (2), Aβ and tau pathology (1), tau pathology (1)
Platelets 4 3 Aβ pathology (2), tau pathology (1)
NeV 8 3 Tau pathology (1), neuroinflammation (1), AD (1)
RBC 2 1 α-synuclein pathology

NeV, Neuronal-enriched extracellular vesicles; RBC, red blood cells.